PolTREG was established as a spin-off from the Medical University of Gdańsk in order to develop and commercialize patented TREG method. PolTREG is the most advanced company in TREGS cellular therapies worldwide, breakthrough therapies for type 1 diabetes (T1D) and multiple sclerosis (MS). PolTREG has very promising results regarding the safety and efficacy of TREGS therapy (completed phase I/II clinical trials in T1D and phase I in MS), ready for the next phase of trials. The company is after EMA Scientific Advice procedure.
| Website | https://poltreg.com/ |
| Employees | 39 (25 on RocketReach) |
| Founded | 2015 |
| Address | ul. Botaniczna 20, Gdańsk, Pomorskie 80-298, PL |
| Phone | +48 512 532 401 |
| Industry | Biotechnology Research |
| Keywords | Advanced Therapies, Cellular Therapies, Cell Based Therapies, Immunotherapy, Breakthrough Therapies, Regenerative Medicine, Cell Therapy, Transplantation, Type 1 Diabetes Treatment, Autoimmune Diseases, Biotechnology, Patented Technology, Clinical Trials, Pharmaceutical Research, Drug Development, Life Sciences, Precision Medicine, Medical Technology, Healthcare Innovation |
| Competitors | Poltrona Frau, Herman Miller, Vitra, GUBI, Etsy, Groupe Roset, Minotti Beirut, Muji Malaysia Sdn Bhd, Cassina, B&B Italia +43 more (view full list) |
Looking for a particular PolTREG S.A. employee's phone or email?
PolTREG S.A. Questions
Karol Ptach is the Chief Operations Officer of PolTREG S.A..
25 people are employed at PolTREG S.A..
PolTREG S.A. is based in Gdańsk, Pomorskie.
Top PolTREG S.A. Employees
Related Companies
